Bausch + Lomb Corporation announced on May 19, 2025, that its majority shareholder, Bausch Health Companies Inc. (BHC), has entered into separate letter agreements with key shareholder groups, including the Icahn Group, the Paulson Group, and the Kavanagh Group. These agreements stipulate that if any group engages in specific actions, such as supporting proxy contests or acquiring significant shares, they must immediately resign from the boards of both BHC and Bausch + Lomb. Additionally, the Icahn Group has waived certain rights related to director appointments. While Bausch + Lomb is not a direct party to these agreements, BHC has committed to supporting management nominees from these groups, provided they refrain from engaging in specified actions. This announcement was detailed in BHC's Form 8-K filed on May 21, 2025.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。